dbo:abstract
|
- مارك فيشمان (بالإنجليزية: Mark Fishman) هو طبيب قلب أمريكي، ولد في 25 يونيو 1947. (ar)
- Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the MGH for patients with complex medical disorders. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals. Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort. He is the author of over 100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease. (en)
|
dbo:academicDiscipline
| |
dbo:almaMater
| |
dbo:award
| |
dbo:citizenship
| |
dbo:institution
| |
dbo:knownFor
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 6259 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:almaMater
| |
dbp:awards
|
- Institute of Medicine member, Fellow of the American Academy of Arts and Sciences (en)
|
dbp:citizenship
| |
dbp:fields
| |
dbp:knownFor
|
- pioneering Zebrafish research in cardiology (en)
|
dbp:name
| |
dbp:wikiPageUsesTemplate
| |
dbp:workplaces
|
- Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School (en)
|
dcterms:subject
| |
gold:hypernym
| |
schema:sameAs
| |
rdf:type
| |
rdfs:comment
|
- مارك فيشمان (بالإنجليزية: Mark Fishman) هو طبيب قلب أمريكي، ولد في 25 يونيو 1947. (ar)
- Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the MGH for patients with complex medical disorders. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals. (en)
|
rdfs:label
|
- مارك فيشمان (ar)
- Mark Fishman (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:academicAdvisor
of | |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is dbp:academicAdvisors
of | |
is foaf:primaryTopic
of | |